These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 30092368
1. Design, synthesis and pharmacological evaluation of new 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one derivatives as potential antitumor agents. Kuang WB, Huang RZ, Qin JL, Lu X, Qin QP, Zou BQ, Chen ZF, Liang H, Zhang Y. Eur J Med Chem; 2018 Sep 05; 157():139-150. PubMed ID: 30092368 [Abstract] [Full Text] [Related]
2. Design, synthesis and pharmacological evaluation of novel 2-chloro-3-(1H-benzo[d]imidazol-2-yl)quinoline derivatives as antitumor agents: in vitro and in vivo antitumor activity, cell cycle arrest and apoptotic response. Kuang WB, Huang RZ, Fang YL, Liang GB, Yang CH, Ma XL, Zhang Y. RSC Adv; 2018 Jul 02; 8(43):24376-24385. PubMed ID: 35539175 [Abstract] [Full Text] [Related]
3. In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues. Wang W, Rayburn ER, Velu SE, Nadkarni DH, Murugesan S, Zhang R. Clin Cancer Res; 2009 May 15; 15(10):3511-8. PubMed ID: 19451594 [Abstract] [Full Text] [Related]
4. Design, synthesis and biological evaluation of naphthalenebenzimidizole platinum (II) complexes as potential antitumor agents. Liang GB, Yu YC, Wei JH, Kuang WB, Chen ZF, Zhang Y. Eur J Med Chem; 2020 Feb 15; 188():112033. PubMed ID: 31923857 [Abstract] [Full Text] [Related]
6. Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents. Zhou P, Huang L, Zhou J, Jiang B, Zhao Y, Deng X, Zhao Q, Li F. Bioorg Med Chem Lett; 2017 Sep 01; 27(17):4185-4189. PubMed ID: 28757067 [Abstract] [Full Text] [Related]
10. Structure-Based Design: Synthesis, X-ray Crystallography, and Biological Evaluation of N-Substituted-4-Hydroxy-2-Quinolone-3-Carboxamides as Potential Cytotoxic Agents. Sabbah DA, Hishmah B, Sweidan K, Bardaweel S, AlDamen M, Zhong HA, Abu Khalaf R, Hasan Ibrahim A, Al-Qirim T, Abu Sheikha G, Mubarak MS. Anticancer Agents Med Chem; 2018 Sep 01; 18(2):263-276. PubMed ID: 28901259 [Abstract] [Full Text] [Related]
11. Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents. Abdelgawad MA, Bakr RB, Omar HA. Bioorg Chem; 2017 Oct 01; 74():82-90. PubMed ID: 28772160 [Abstract] [Full Text] [Related]
12. Design, synthesis, and mechanism of action of 2-(3-hydroxy-5-methoxyphenyl)-6-pyrrolidinylquinolin-4-one as a potent anticancer lead. Cheng YY, Liu CY, Tsai MT, Lin HY, Yang JS, Wu TS, Kuo SC, Huang LJ, Lee KH. Bioorg Med Chem Lett; 2013 Sep 15; 23(18):5223-7. PubMed ID: 23916255 [Abstract] [Full Text] [Related]
16. Preparation of Rhodium(III) complexes with 2(1H)-quinolinone derivatives and evaluation of their in vitro and in vivo antitumor activity. Lu X, Wu YM, Yang JM, Ma FE, Li LP, Chen S, Zhang Y, Ni QL, Pan YM, Hong X, Peng Y. Eur J Med Chem; 2018 May 10; 151():226-236. PubMed ID: 29614419 [Abstract] [Full Text] [Related]
17. Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents. Wu LT, Jiang Z, Shen JJ, Yi H, Zhan YC, Sha MQ, Wang Z, Xue ST, Li ZR. Eur J Med Chem; 2016 May 23; 114():328-36. PubMed ID: 27017265 [Abstract] [Full Text] [Related]
18. Synthesis, antiproliferative activity and DNA/RNA-binding properties of mono- and bis-(1,2,3-triazolyl)-appended benzimidazo[1,2-a]quinoline derivatives. Meščić Macan A, Perin N, Jakopec S, Mioč M, Stojković MR, Kralj M, Hranjec M, Raić-Malić S. Eur J Med Chem; 2020 Jan 01; 185():111845. PubMed ID: 31718941 [Abstract] [Full Text] [Related]
19. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents. Shao KP, Zhang XY, Chen PJ, Xue DQ, He P, Ma LY, Zheng JX, Zhang QR, Liu HM. Bioorg Med Chem Lett; 2014 Aug 15; 24(16):3877-81. PubMed ID: 25001482 [Abstract] [Full Text] [Related]